TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
Objective: To determine the trends of physicians and neurologists in prescribing anti-platelet agents for secondary prevention of non-cardio embolic stroke after 3 months of stroke. Study Design: A descriptive study. Place and Duration of Study: Combined Military Hospital (CMH) Lahore over...
Guardado en:
Autores principales: | Muhammad Tariq, Faisal Naveed Akhtar, Muhammad Aamir Khan Babar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f55ed5087e6b422eab8f810dc12a9e11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
por: E. Y. Kitaeva, et al.
Publicado: (2017) -
Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis
por: Dariusz Kotlęga, et al.
Publicado: (2019) -
Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Yinping Guo, et al.
Publicado: (2021) -
A Novel Thromboplastin-Based Rat Model of Ischemic Stroke
por: Irina V. Ostrova, et al.
Publicado: (2021) -
Acute Ischemic Stroke With Mild Symptoms–To Thrombolyse or Not to Thrombolyse?
por: Julia Ferrari, et al.
Publicado: (2021)